FDA Vaccine Panel Endorses Pfizer-BioNTech COVID-19 Vaccine
After a day of public deliberation and debate, the members of the Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted on the question: Based on the totality of scientific evidence available, do the benefits of the Pfizer-BioNTech COVID-19 Vaccine outweigh its risks for use in individuals 16 years of age and older?
The vote was 17 Yes, 4 No, and 1 Abstention.
Considering that the United Kingdom, Canada, and even Saudi Arabia have already approve
Article from Latest – Reason.com